Where Can I Buy Life Extension Products UPD
The Product Life Extension business model focuses on lengthening the time period that a product can be used before disposing of it. The goal is to maximize both lifespan and utilization, by increasing the value extracted from products before they are discarded.
where can i buy life extension products
In the future, expect to see the growth of more businesses delivering creative solutions for extending product life. They bring not just cost savings to their customers, but also environmental credibility. Already, used, repaired and refurbished products have become more socially acceptable or in the case of fashion, in demand. Indeed, the overall resale market for is expected to hit $41 billion by 2022, far outpacing growth rates from traditional retail.
Shelf life items are products that are effective, useful or suitable for consumption for a limited time period. They are expected to deteriorate or become unstable to the degree that a storage period must be assigned to assure that the material will perform satisfactorily in service. In short, the item spoils or will not perform its intended function for the customer after long-term, or even short-term, storage. All of these shelf life items are recognized for their sensitivity to light, temperature, moisture or handling. Packaging deterioration and improper storage or preservation can also adversely affect shelf life.
The "Program Objectives" under 41CFR 101-27.203 cite the need to identify those items having a limited serviceable life. In order to assure maximum customer use of shelf life items, each of these items must be identified, including newly procured items having limited serviceability. Expired shelf life items no longer support the customer's mission, and incur additional costs for disposal. DoD customers maintain stocks of shelf life products to support their mission. GSA is sensitive to their needs concerning these items.
The role of each DoD Inventory Control Point (ICP) is to determine storage standards for deteriorative items that they manage, and to arrange for laboratory shelf life extension tests when their Installation Supply Activities request such tests. Storage standards (including length of shelf life and whether an item requires only a visual inspection or a full laboratory test in order to extend shelf life) are recorded in the on-line Material Quality Control Storage Standards (MQCSS). Each ICP has update rights to this system. The type of test required on each item (visual inspection or laboratory testing) is determined by the managing ICP.
If an installation finds that shelf life extension information is not available in the QSL for one of its items, staff can contact their service ICP for further instructions on possible extensions. Laboratory test requests are only allowed when there has not already been a shelf life test for that NSN, Manufacturer, Lot and Batch, and when the quantities of material in question warrant the expense of laboratory testing. When these tests are accomplished, test results and extension data are entered into the QSL.
The Administration for Strategic Preparedness and Response (ASPR) and the Food and Drug Administration (FDA) announce the authorization of an extension to the shelf life for all lots of the Merck antiviral therapy, Lagevrio (molnupiravir) capsules from 24 to months to 30 months. Lagevrio capsules are currently authorized for emergency use for the treatment of mild-to-moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing who are at high risk for progressing to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options approved or authorized by FDA are not accessible or clinically appropriate.
The Administration for Strategic Preparedness and Response (ASPR) and the Food and Drug Administration (FDA) announces the authorization of a shelf life extension to 24 months for the Pfizer antiviral therapy, Paxlovid (nirmatrelvir tablets and ritonavir tablets co-packaged for oral use), which is currently authorized for emergency use for the treatment of mild-to-moderate COVID-19 in certain adults and pediatric patients (12 years of age and older weighing at least 40kg).
Electrical product apparatus life extension services are important when working with new and used electrical equipment in order to prolong the electrical product's life well beyond what was originally expected. Our experienced electrical staff at Voyten Electric can work with you to ensure the best quality apparatus life extension services.
Life extension is the concept of extending the human lifespan, either modestly through improvements in medicine or dramatically by increasing the maximum lifespan beyond its generally-settled limit of 125 years.
Several researchers in the area, along with "life extensionists", "immortalists" or "longevists" (those who wish to achieve longer lives themselves), postulate that future breakthroughs in tissue rejuvenation, stem cells, regenerative medicine, molecular repair, gene therapy, pharmaceuticals, and organ replacement (such as with artificial organs or xenotransplantations) will eventually enable humans to have indefinite lifespans (agerasia) through complete rejuvenation to a healthy youthful condition. The ethical ramifications, if life extension becomes a possibility, are debated by bioethicists.
The longest documented human lifespan is 122 years 164 days, the case of Jeanne Calment who according to records was born in 1875 and died in 1997, whereas the maximum lifespan of a wildtype mouse, commonly used as a model in research on aging, is about three years. Genetic differences between humans and mice that may account for these different aging rates include differences in efficiency of DNA repair, antioxidant defenses, energy metabolism, proteostasis maintenance, and recycling mechanisms such as autophagy.
Mechanistically, research suggests that the gut microbiome, which varies per person and changes throughout lifespan, is also involved in the beneficial effects, due to which various diet supplementations with prebiotics, various diverse (multi-strain) probiotics and synbiotics, and fecal microbiota transplantation are being investigated for life extension, mainly for prolonging healthspan, with many important questions being unresolved.
In 2003, Doubleday published "The Immortal Cell: One Scientist's Quest to Solve the Mystery of Human Aging," by Michael D. West. West emphasised the potential role of embryonic stem cells in life extension.
Other modern life extensionists include writer Gennady Stolyarov, who insists that death is "the enemy of us all, to be fought with medicine, science, and technology"; transhumanist philosopher Zoltan Istvan, who proposes that the "transhumanist must safeguard one's own existence above all else"; futurist George Dvorsky, who considers aging to be a problem that desperately needs to be solved; and recording artist Steve Aoki, who has been called "one of the most prolific campaigners for life extension".
Leon Kass (chairman of the US President's Council on Bioethics from 2001 to 2005) has questioned whether potential exacerbation of overpopulation problems would make life extension unethical. He states his opposition to life extension with the words:
John Harris, former editor-in-chief of the Journal of Medical Ethics, argues that as long as life is worth living, according to the person himself, we have a powerful moral imperative to save the life and thus to develop and offer life extension therapies to those who want them.
Transhumanist philosopher Nick Bostrom has argued that any technological advances in life extension must be equitably distributed and not restricted to a privileged few. In an extended metaphor entitled "The Fable of the Dragon-Tyrant", Bostrom envisions death as a monstrous dragon who demands human sacrifices. In the fable, after a lengthy debate between those who believe the dragon is a fact of life and those who believe the dragon can and should be destroyed, the dragon is finally killed. Bostrom argues that political inaction allowed many preventable human deaths to occur.
Controversy about life extension is due to fear of overpopulation and possible effects on society. Biogerontologist Aubrey De Grey counters the overpopulation critique by pointing out that the therapy could postpone or eliminate menopause, allowing women to space out their pregnancies over more years and thus decreasing the yearly population growth rate. Moreover, the philosopher and futurist Max More argues that, given the fact the worldwide population growth rate is slowing down and is projected to eventually stabilize and begin falling, superlongevity would be unlikely to contribute to overpopulation.
A Spring 2013 Pew Research poll in the United States found that 38% of Americans would want life extension treatments, and 56% would reject it. However, it also found that 68% believed most people would want it and that only 4% consider an "ideal lifespan" to be more than 120 years. The median "ideal lifespan" was 91 years of age and the majority of the public (63%) viewed medical advances aimed at prolonging life as generally good. 41% of Americans believed that radical life extension (RLE) would be good for society, while 51% said they believed it would be bad for society. One possibility for why 56% of Americans claim they would reject life extension treatments may be due to the cultural perception that living longer would result in a longer period of decrepitude, and that the elderly in our current society are unhealthy.
The discussion whether aging should be viewed as a disease or not has important implications. One view is, this would stimulate pharmaceutical companies to develop life extension therapies and in the United States of America, it would also increase the regulation of the anti-aging market by the Food and Drug Administration (FDA). Anti-aging now falls under the regulations for cosmetic medicine which are less tight than those for drugs. 041b061a72